We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+7.87%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$15.9B
AUM Growth
+$1.24B
(+8.5%)
Cap. Flow
+$523M
Cap. Flow
% of AUM
3.3%
Top 10 Holdings %
Top 10 Hldgs %
35.05%
Holding
1,298
New
139
Increased
794
Reduced
319
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$228M |
| 2 |
KraneShares CSI China Internet ETF
KWEB
|
+$41.5M |
| 3 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$35.7M |
| 4 |
Intel
INTC
|
+$34.7M |
| 5 |
Blackstone
BX
|
+$34.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
A10 Networks
ATEN
|
+$258M |
| 2 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$255M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$197M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$83.7M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.02% |
| 2 | Financials | 19.16% |
| 3 | Energy | 5.34% |
| 4 | Healthcare | 4.01% |
| 5 | Industrials | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
CVS Health
CVS
$134B
| $2.27M | 0.01% |
27,252
+1,113
| +4% | +$91.1K |
|
652
Independent Bank
INDB
$4.02B
| $2.26M | 0.01% |
29,888
+12,323
| +70% | +$991K |
|
653
Akebia Therapeutics
AKBA
$362M
| $2.25M | 0.01% |
594,946
-328,008
| -36% | -$1.1M |
|
|
GBT
654
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.25M | 0.01% |
64,184
-11,492
| -15% | -$449K |
|
655
Old National Bancorp
ONB
$10.1B
| $2.24M | 0.01% |
127,098
+31,190
| +33% | +$590K |
|
|
VXRT
656
DELISTED
Vaxart
VXRT
| $2.23M | 0.01% |
298,456
-195,883
| -40% | -$1.37M |
|
657
American Airlines Group
AAL
$10.2B
| $2.23M | 0.01% |
105,052
+46,562
| +80% | +$1.05M |
|
658
uniQure
QURE
$2.93B
| $2.23M | 0.01% |
72,339
-115,473
| -61% | -$3.87M |
|
659
Brighthouse Financial
BHF
$3.64B
| $2.22M | 0.01% |
48,751
+4,349
| +10% | +$204K |
|
660
Columbia Banking Systems
COLB
$8.84B
| $2.2M | 0.01% |
56,994
+11,034
| +24% | +$469K |
|
661
Immunovant
IMVT
$8.11B
| $2.19M | 0.01% |
207,189
+11,091
| +6% | +$155K |
|
|
KRTX
662
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.19M | 0.01% |
19,184
-8,710
| -31% | -$1.02M |
|
663
Equity Residential
EQR
$25.2B
| $2.18M | 0.01% |
28,327
+8,730
| +45% | +$660K |
|
|
GAP
664
The Gap Inc
GAP
$7.34B
| $2.18M | 0.01% |
64,676
+9,011
| +16% | +$297K |
|
|
AMTI
665
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $2.17M | 0.01% |
47,405
+35,254
| +290% | +$1.67M |
|
|
IBTX
666
DELISTED
Independent Bank Group, Inc.
IBTX
| $2.15M | 0.01% |
29,069
+1,576
| +6% | +$119K |
|
667
AXIS Capital
AXS
$7.67B
| $2.15M | 0.01% |
43,850
+2,050
| +5% | +$109K |
|
668
Northern Oil and Gas
NOG
$2.27B
| $2.15M | 0.01% |
+103,403
| New | +$1.69M |
|
|
HGEN
669
DELISTED
HUMANIGEN, INC.
HGEN
| $2.15M | 0.01% |
123,564
-83,765
| -40% | -$1.53M |
|
|
IGMS
670
DELISTED
IGM Biosciences
IGMS
| $2.14M | 0.01% |
25,695
-12,242
| -32% | -$907K |
|
|
MAXR
671
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $2.13M | 0.01% |
53,397
+8,313
| +18% | +$296K |
|
672
Ardelyx
ARDX
$1.25B
| $2.12M | 0.01% |
279,355
+112,763
| +68% | +$834K |
|
|
CDMO
673
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.09M | 0.01% |
+81,607
| New | +$1.74M |
|
|
ESPR
674
DELISTED
Esperion Therapeutics
ESPR
| $2.09M | 0.01% |
98,918
-10,897
| -10% | -$262K |
|
675
Nurix Therapeutics
NRIX
$2.45B
| $2.09M | 0.01% |
78,690
+10,863
| +16% | +$319K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Rafferty Asset Management held 1,298 positions worth $15.9B, up 8.5% from $14.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management deployed $523M of net new capital in Q2 2021, opening 139 new positions and adding to 794 existing holdings. Its largest new stake was Blackstone: 386,473 shares worth $37.5M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $197M trimmed.
- Rafferty Asset Management's largest Q2 2021 buy was Blackstone: 386,473 shares worth $37.5M.
- Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $228M increase.
- Rafferty Asset Management's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $197M.
- Rafferty Asset Management fully exited A10 Networks in Q2 2021, selling an estimated $258M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $15.9B portfolio in Q2 2021.
- Rafferty Asset Management opened 139 new positions and closed 45 in Q2 2021.
- Rafferty Asset Management's portfolio value rose 8.5% quarter-over-quarter to $15.9B.
Based on Rafferty Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.